BPCR - BioPharma Credit PLC - Stock & Dividends
Exchange: London Exchange • Country: United Kingdom • Currency: USD • Type: Common Stock • ISIN: GB00BDGKMY29
Loans, Royalties, Debt, Securities, Pharmaceuticals
BioPharma Credit PLC is a unique investment trust that focuses on generating returns through interest-bearing debt assets. These debt assets are carefully selected and secured by royalties or other cash flows derived from the sales of approved life sciences products, providing a stable source of income.
The company's investment strategy is centered around providing financing solutions to pharmaceutical and biotechnology companies, allowing them to access capital while sharing the risks and rewards of their innovative products. By doing so, BioPharma Credit PLC is able to tap into the growing demand for life sciences investments, while also providing a diversified portfolio of debt assets.
As a London-based company, incorporated in 2016, BioPharma Credit PLC is well-positioned to leverage its expertise in the life sciences sector, as well as its access to the global debt markets. The company's investment team has a deep understanding of the complex dynamics of the pharmaceutical and biotechnology industries, enabling them to identify and invest in debt assets that offer attractive returns while minimizing risk.
For investors seeking a unique investment opportunity that combines the stability of debt assets with the growth potential of the life sciences sector, BioPharma Credit PLC offers an attractive proposition. With its strong track record and experienced investment team, the company is well-placed to continue delivering returns to its shareholders while contributing to the development of innovative life sciences products.
For more information about BioPharma Credit PLC, please visit their website at https://www.bpcruk.com.
Drawdown (Underwater) Chart
BPCR Stock Overview
Market Cap in USD | 105,388m |
Sector | Financial Services |
Industry | Asset Management |
GiC SubIndustry | Asset Management & Custody Banks |
TER | 0.00% |
IPO / Inception |
BPCR Stock Ratings
Growth 5y | 79.1 |
Fundamental | 28.3 |
Dividend | 87.4 |
Rel. Performance vs Sector | -1.98 |
Analysts | - |
Fair Price Momentum | 1.00 USD |
Fair Price DCF | 2.57 USD |
BPCR Dividends
Dividend Yield 12m | 21.15% |
Yield on Cost 5y | 30.32% |
Dividends CAGR 5y | 8.06% |
Payout Consistency | 95.0% |
BPCR Growth Ratios
Growth 12m | 21.21% |
Growth Correlation 12m | 73% |
Growth Correlation 3m | 16.1% |
CAGR 5y | 7.65% |
CAGR/Mean DD 5y | 2.50 |
Sharpe Ratio 12m | 1.13 |
Alpha vs SP500 12m | 11.67 |
Beta vs SP500 5y weekly | 0.13 |
ValueRay RSI | 30.23 |
Volatility GJR Garch 1y | 14.60% |
Price / SMA 50 | -2.27% |
Price / SMA 200 | 2.38% |
Current Volume | 763.5k |
Average Volume 20d | 1435.7k |
External Links for BPCR Stock
As of October 22, 2024, the stock is trading at USD 0.86 with a total of 763,474 shares traded.
Over the past week, the price has changed by -1.14%, over one month by -0.48%, over three months by +2.22% and over the past year by +21.50%.
According to ValueRays Forecast Model, BPCR BioPharma Credit PLC will be worth about 1.1 in October 2025. The stock is currently trading at 0.86. This means that the stock has a potential upside of +25.58%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 1.1 | 25.6 |